Learning Centre

UNICEF’s Global HIV Response 2017–2021 Addressing the global HIV epidemic among pregnant women, mothers, children and adolescents

As the number of people accessing life-saving drugs for HIV has risen, there has been an increasing sense that the end of AIDS was near. But for children and adolescents, the situation remains grave.

Avec l’augmentation du nombre de personnes ayant accès à des médicaments salvateurs, le sentiment que la fin du sida était proche s’est généralisé.

Intervention mondiale 2017-2021 de l’UNICEF contre le VIH Faire face à l’épidémie de VIH chez les enfants et les adolescents, les femmes enceintes et les mères

Towards an end to AIDS in children, adolescents and young women.

UNICEF has long been at the heart of global efforts to put the HIV epidemic into an irreversible and rapid retreat.

WHO launched in May the long-awaited Global Accelerated Action for the Health of Adolescents (AA-HA!): Guidance to Support Country Implementation. 

The International HIV/AIDS Alliance published in May 2017 a good practice guide on Adolescent HIV programming.

A Compendium of Selected Projects in PEPFAR-Supported Countries

Reaching unreachable population: multi-collaboration framework to improve young key population access towards HIV-related services in demonstration site of Bandung, Indonesia.

The purpose of the report is to showcase the significant contributions of many partners to research, innovations, community mobilization, programmes and policy actions aimed at ending the AIDS epidemic in adolescents in su

In this report, UNAIDS is announcing that 18.2 million people now have access to HIV treatment. The Fast-Track response is working. Increasing treatment coverage is reducing AIDS-related deaths among adults and children.

Start Free, Stay Free, AIDS Free initiative aims to galvanize global momentum around a shared and ambitious agenda to build on the progress achieved under the Global Plan towards the elimination of new HIV infections among

This document updates the 2013 consolidated guidelines on the use of antiretroviral drugs following an extensive review of evidence and consultations in mid-2015, shared at the end of 2015, and now published in full in 201

This document was created by ICAP’s Clinical and Training Unit with valuable input from our teams in Swaziland, Mozambique, Kenya, and Cote d’Ivoire.

The life course through childhood, adolescence, adulthood and old age affects health, wellbeing and earnings. 

In response to a longstanding demand for a heat-stable and easy to administer formulation of ritonavir boosted lopinavir (LPV/r) for infants and young children, a new formulation in pellet form is now available.